China Isotope & Radiation Stock

China Isotope & Radiation Equity 2024

China Isotope & Radiation Equity

4.69 B CNY

Ticker

1763.HK

ISIN

CNE1000031F4

In 2024, China Isotope & Radiation's equity was 4.69 B CNY, a 5.03% increase from the 4.47 B CNY equity in the previous year.

China Isotope & Radiation Aktienanalyse

What does China Isotope & Radiation do?

China Isotope & Radiation Corp (CIRC) is a Chinese company specialized in the production and sale of nuclear products and services. It was founded in 1990 and is headquartered in Beijing. CIRC's history dates back to the 1950s when China conducted atomic experiments. In the 1960s, the country began producing radioisotopes for use in medicine, industry, and agriculture. CIRC was later established as a company to organize the production and sale of these products and services. CIRC's business model is based on the production and sale of radioisotopes and their applications in various fields such as medicine, industry, environmental monitoring, and research. The company aims to provide high-quality products and services to meet its customers' needs. CIRC has different divisions focusing on the various applications of radioisotopes. One important division is the medical application, which focuses on the production of radioisotopes for cancer diagnosis and therapy, cardiovascular diseases, and other illnesses. The company also produces radioactive drugs that can be used in the diagnosis and treatment of various diseases. Another important division of CIRC is the industrial application of radioisotopes, which focuses on the measurement of thickness, density, and radiation in various products and materials. The company also offers services in surface treatment and material testing. CIRC is also involved in environmental monitoring, offering products and services for the measurement and monitoring of air, water, and soil pollution. The company is also engaged in research and development, developing new products and applications of radioisotopes. CIRC offers a wide range of products, including various types of radioisotopes, radioactive drugs, radiation measurement devices and systems, as well as instruments and equipment for radioisotope production. CIRC is a leading provider of radioisotopes and related services in China and has a strong presence in other countries as well. The company has established itself as a reliable partner for customers in various industries and is committed to the highest quality and customer satisfaction. China Isotope & Radiation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing China Isotope & Radiation's Equity

China Isotope & Radiation's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding China Isotope & Radiation's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating China Isotope & Radiation's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

China Isotope & Radiation's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in China Isotope & Radiation’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about China Isotope & Radiation stock

What is the equity of China Isotope & Radiation this year?

China Isotope & Radiation has equity of 4.69 B CNY this year.

What was the equity of China Isotope & Radiation compared to the previous year?

The equity of China Isotope & Radiation has increased/decreased by 5.03% increased compared to the previous year.

What impact does a high equity have on investors of China Isotope & Radiation?

A high equity is advantageous for investors of China Isotope & Radiation as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of China Isotope & Radiation?

A low equity can be a risk for investors of China Isotope & Radiation, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of China Isotope & Radiation affect the company?

An increase in equity of China Isotope & Radiation can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of China Isotope & Radiation affect the company?

A reduction in equity of China Isotope & Radiation can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of China Isotope & Radiation?

Some factors that can affect the equity of China Isotope & Radiation include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of China Isotope & Radiation so important for investors?

The equity of China Isotope & Radiation is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can China Isotope & Radiation take to change the equity?

To change equity, China Isotope & Radiation can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does China Isotope & Radiation pay?

Over the past 12 months, China Isotope & Radiation paid a dividend of 0.48 CNY . This corresponds to a dividend yield of about 5.55 %. For the coming 12 months, China Isotope & Radiation is expected to pay a dividend of 0.51 CNY.

What is the dividend yield of China Isotope & Radiation?

The current dividend yield of China Isotope & Radiation is 5.55 %.

When does China Isotope & Radiation pay dividends?

China Isotope & Radiation pays a quarterly dividend. This is distributed in the months of August, July, July, October.

How secure is the dividend of China Isotope & Radiation?

China Isotope & Radiation paid dividends every year for the past 8 years.

What is the dividend of China Isotope & Radiation?

For the upcoming 12 months, dividends amounting to 0.51 CNY are expected. This corresponds to a dividend yield of 5.89 %.

In which sector is China Isotope & Radiation located?

China Isotope & Radiation is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Isotope & Radiation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Isotope & Radiation from 11/22/2024 amounting to 0.072 CNY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did China Isotope & Radiation pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of China Isotope & Radiation in the year 2023?

In the year 2023, China Isotope & Radiation distributed 0.44 CNY as dividends.

In which currency does China Isotope & Radiation pay out the dividend?

The dividends of China Isotope & Radiation are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Isotope & Radiation

Our stock analysis for China Isotope & Radiation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Isotope & Radiation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.